Following ARTEMIS, RISE, and NEUROTECH in 2021, two new TUM Innovation Networks are about to start this spring.
eXprt (Exoskeleton and wearables enhanced prevention and treatment) and NextGenDrugs (Next generation drug design) have been chosen by TUM Board of Management for a four-year funding…
[read more]